Top Trending LinkedIn Posts about clinical trials

🔥📅 Save the date: 20 May -International Clinical Trials Day Public Discussion on "Patient Recruitment & Retention" online and in person at St

Delighted to see the inclusion of the reputed Omega Hospitals into the network of data driven cancer hospitals in #India.

Congratulations to Oncoshot India

Join me at the Clinical Trial Supply Forum where we'll explore how to transform the supply chain to better serve patients in clinical

Exciting advancements in cancer treatment are on the horizon with the development of therapeutic cancer vaccines. Unlike traditional vaccines aimed at preventing diseases,

Clinical trials struggle with issues of mistrust, perceived injustice, and limited scope of biomedical knowledge due to the exclusion of diverse populations.

Andrea

Clinical Trials Start-Up Lead Position in Dallas, Texas,
Reach out to Benjamin Welsh!

To Catch a Thief: How Source Documentation in Clinical Trials Protects Us All...

We all know it’s good practice to source-document our clinical trial

Ted Trafford joins Liam on this week’s podcast episode.

Ted is the Director of Business Development at Probity Medical Research Inc. (PMR). PMR

The Saudi government has introduced several incentives and programs to foster pharmaceutical innovation and clinical trials:

Expert Citizenship: Granting citizenship to exceptional global talents

Clinical trials are the backbone of medical advancements, yet implementing them comes with a unique set of challenges.

Ever wondered what the latest

Clinical trials can sometimes take years and cost many of millions of dollars.

Why?

And how can AI help bring faster and better

🎙️ Exciting News! 🎙️

We are thrilled to announce the launch of our brand-new podcast: Innovating Clinical Trials! 🚀

Join Ted Trafford and me as

Clinical Trials to Watch in 2024 | Follow Brindha Chandrasekaran

Trastuzumab deruxtecan (AstraZeneca)
Phase: 3b/4
Lead Indication: Breast cancer
Description: Efficacy and safety of ADC in HER2-positive

Clinical trials are costly and slow, have low success rates but are essential in improving healthcare. Let’s see the various ways AI can

Don't make this investment mistake in your clinical trial.

3 lessons to improve your probability of success.

It is well-documented that over 85% of trials

Innovating Clinical Trials – Podcast Episode 2: Clinical Trial Metrics

To build relationships between sponsors, CROs and sites, transparency is key.

Join Ted Trafford

Clinical trials are costly and slow, have low success rates but are essential in improving healthcare.

I described various ways AI can help

𝗧𝗵𝗲𝗿𝗲 𝗶𝘀 𝗮 𝗹𝗼𝘁 𝗼𝗳 𝗺𝗶𝘀𝘁𝗿𝘂𝘀𝘁 𝗮𝗿𝗼𝘂𝗻𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀. 𝗛𝗼𝘄 𝗱𝗼 𝘄𝗲 𝘁𝗮𝗰𝗸𝗹𝗲 𝗶𝘁?

The elephant in the room: Clinical trials often

Innovating Clinical Trials Episode 5 is here, and it's a good one.

Picture this:

You're the sponsor of a study, and there's this

Even after all these years, I still struggle with this fundamental truth in clinical trials….

Alright, imagine you're on a quest to make the

Clinical trials and a classic 80's movie...

Okay, stick with me here.

Imagine clinical trials as an epic quest.

Now, throw in a dash

Clinical trials data publication now more transparent in the EU

Nice article from the Euobserver that summarizes the benefits of CTIS not least the

Ensuring Accurate Dose Calculation in Clinical Trials with IRT

Accurate dose calculation is crucial for patient safety and reliable trial outcomes. Interactive Response Technology

Sandy Robbins joins Liam on this week’s clinical trial podcast episode.

Sandy is the Vice President of Commercial Operations at MMS.

Sandy has built

7 principles of highly effective enrollment for clinical trials.

Over the last 17 years, I have made every mistake in the clinical trial delivery

Why Clinical Trial Conversations Keep Failing and 4 things Sponsors can do about it...

Let’s be honest: communicating a clinical trial to potential participants

Clinical trials are back! For 13 days, a bug kept new trials from being posted to clinicaltrials.gov.

During that time 275 new cancer trials

Clinical Trials to Watch in 2024 | Follow Brindha Chandrasekaran

Trastuzumab deruxtecan (AstraZeneca)
Phase: 3b/4
Lead Indication: Breast cancer
Description: Efficacy and safety of ADC in HER2-positive

Clinical trials are on the way; exciting yet time-consuming 🔬 🔭

Thanks to MedWatch for featuring us; also, read more about the science

Clinical trials and research terminology to keep you learning research.